REBECCA JACKSON: Open Payments
NPI 1609102243 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 28 payments from 13 companies in 2025. Trend: 2023 $824 · 2024 $1,071 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $416 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Galderma Laboratories, L.P. | 1 | $82 |
| Edwards Lifesciences Corporation | 2 | $64 |
| Amgen Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| HEARTFLOW, INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
Products named: BOTOX, LEQVIO, REPATHA, NEXLETOL, JARDIANCE, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, FARXIGA, SAPIEN 3 Ultra RESILIA.
Industry payments across GA — which companies pay providers there.
